Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by ronrydellon Apr 03, 2015 9:38pm

210 Views

Post# 23596166

RE:RE:SOARING BIOTECH OUTLOOK

Good post on seeking Alpha..IMHO reason so many people lose money is not knowing when to sell...the greed builds and investors look for just "one more dollar" and then it's too late.

if RVX starts to move up,in a few months I'll be gone way before the "big blockbuster" number that COULD Happen. Same with BIND. A piece of the pie for me is better then no pie at all.

Just sayin'

Bullboard Posts

Who, why, and what of the great "Crypto Surge"